Showing results (621-630 of 678) with videos related to
Sort By:
Pageof 68
Journal of Dairy Science|January 23, 2017
Use of genotype × environment interaction model to accommodate genetic heterogeneity for residual feed intake, dry matter intake, net energy in milk, and metabolic body weight in dairy cattleC Yao, G de Los Campos, M J VandeHaar, et al.Biorxiv : the Preprint Server for Biology|July 9, 2020
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discoveryA Mulay, B Konda, G Garcia, et al.Journal of Hepatocellular Carcinoma|August 31, 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinomaArmeen Mahvash, Ravi Murthy, Bruno C Odisio, et al.Frontiers in Oncology|October 24, 2022
Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinomaAhmed O Kaseb, Abedul Haque, Deeksha Vishwamitra, et al.International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patientsZhongxing Liao, Zhen Zhang, Jing Jin, et al.Allergy|September 26, 2017
A composite of exhaled LTB4 , LXA4 , FeNO, and FEV1 as an "asthma classification ratio" characterizes childhood asthmaL-C Chen, H-M Tseng, M-L Kuo, et al.Current Oncology (Toronto, Ont.)|February 26, 2026
Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine TumorJin Guo, Kever A Lewis, Laura Prakash, et al.Cancer Science|October 22, 2017
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysisNicola Fazio, Roberto Buzzoni, Gianfranco Delle Fave, et al.Nature Communications|May 13, 2022
Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδYi Liu, Yasunori Deguchi, Daoyan Wei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.Pageof 68